Publication: Colaboración con universidades y desempeño innovador en la industria farmaceútica española (2003-2005)
Loading...
Identifiers
Publication date
2008
Defense date
Advisors
Tutors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Impact
Export
Abstract
FUNDAMENTO y OBJETIVOS: Se estudia el efecto en la innovación farmacéutica de la cooperación entre universidades y empresas farmacéuticas en España. De modo análogo, se considera el efecto que tiene la universidad como fuente de información para la innovación en medicamentos. MATER IAL Y MeTOOO: Se emplean datos procedentes del panel de innovación tecnológica (PITEC) elaborado a partir de las encuestas de innovación de los años 2003 a 2005. Para un total de 132 empresas, se dispone de información de su actividad innovadora (cuatro indicadores), la cooperación con universidades, así como la utilidad del conocimiento que éstas generan. También se emplean variables de control como el tamaño del gasto en 1+0 o la actividad en biotecnología. R ESULlAOOS: El efecto de la cooperación con universidades es positivo y significativo (p < 0,01). Además se observa un efecto positivo de la 1+0 en biotecnología. De modo similar, el efecto de la universidad como fuente de información para la innovación es igualmente positivo (p < 0,01). CONCLUSIONES: Las empresas farmacéuticas que han cooperado con universidades tienen una mayor probabilidad de solicitar patentes, así como de que éstas les sean concedidas. Además, la proporción de ventas de productos nuevos es sensiblemente mayor en las empresas que han cooperado con universidades que en las que no lo hacen.----------------------------------------------------------------------
BACKGROUND ANO OBJECTIVES: This article examines, on the one hand, the impact of the cooperation between universities and industry on the performance of innovative activities conducted by pharmaceutical firms in Spain and, on the other hand, the article assesses the impact of universities as a source of information for the innovative activities of the Spanish pharmaceutical industry. MATERIAL ANO METHOO: Data were drawn from the panel of technological innovation, based on the innovation surveys from 2003 to 2005. The survey included 132 pharmaceutical firms and information was available on the firms' innovative outputs (four indicators). cooperation with universities, and the firms' assessment of the importance of universities as an information source for innovative activities. Firm size. R&D expenditures and the use of biotechnology were used as control variables. R ESULTS: The impact of cooperation with universities was found to be positive and significant (p > 0.01). Moreover. the results show a positive impact of both the use of biotechnology and the use of universities as a source of information on firms' innovative performance (p < 0.01). CONCLUSIONS: Pharmaceutical firms that cooperate with universities are more likely to apply for patents and to be granted them. Moreover, the share of sales from new products is larger among firms that have cooperated with universities than among those that have noto
BACKGROUND ANO OBJECTIVES: This article examines, on the one hand, the impact of the cooperation between universities and industry on the performance of innovative activities conducted by pharmaceutical firms in Spain and, on the other hand, the article assesses the impact of universities as a source of information for the innovative activities of the Spanish pharmaceutical industry. MATERIAL ANO METHOO: Data were drawn from the panel of technological innovation, based on the innovation surveys from 2003 to 2005. The survey included 132 pharmaceutical firms and information was available on the firms' innovative outputs (four indicators). cooperation with universities, and the firms' assessment of the importance of universities as an information source for innovative activities. Firm size. R&D expenditures and the use of biotechnology were used as control variables. R ESULTS: The impact of cooperation with universities was found to be positive and significant (p > 0.01). Moreover. the results show a positive impact of both the use of biotechnology and the use of universities as a source of information on firms' innovative performance (p < 0.01). CONCLUSIONS: Pharmaceutical firms that cooperate with universities are more likely to apply for patents and to be granted them. Moreover, the share of sales from new products is larger among firms that have cooperated with universities than among those that have noto
Description
Ejemplar dedicado a: Evaluación del impacto socioeconómico de la investigación biomédica
Keywords
Innovación, Industria farmacéutica, Cooperación con universidades, Innovation, Pharmaceutical industry, Cooperation with universities
Bibliographic citation
Medicina clínica, v. 131, nº extra 5, 2008, pp. 66-70